BBP Fail-to-Deliver

Virtus Biotech ETF (BBP) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $36.3M, listed on AMEX, carrying a beta of 0.80 to the broader market. The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA. public since 2014-12-17.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-04-30
Latest FTD Quantity
74
Latest Price
$83.35
30-Day Avg FTD
634
30-Day Total FTD
19.0K

Showing 30 days of SEC fail-to-deliver data for Virtus Biotech ETF.

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked BBP fail to deliver questions

What is the latest BBP fail-to-deliver count?
As of Apr 30, 2026, Virtus Biotech ETF (BBP) fail-to-deliver quantity is 74 shares, with a 30-day average of 634 shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do BBP FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.